Return to previous page

HMM304 - Therapeutic Development

Unit details

Year2017 unit information
Enrolment modes:Trimester 2: Burwood (Melbourne), Waurn Ponds (Geelong)
Credit point(s):1
EFTSL value:0.125
Unit chair:

Tamsyn Crowley

Prerequisite:

HMM202 or SLE212

Corequisite:

Nil

Incompatible with:

Nil

Contact hours:

1 x 2 hour class per week and 1 x 1 hour (equivalent) online class per week and 1 x 1 hour seminar per week

Content

This unit describes how therapeutic targets are identified and how new therapies are developed for human/animal use. It will provide an overview of the major therapeutic classes, including synthetic compounds, natural products, vaccines, nutriceuticals and other biological agents. This unit covers the therapeutic development pipeline, encompassing target identification and validation, therapeutic discovery and development, pre-clinical trials and toxicity testing. In particular, this unit will focus on therapeutics developed to treat cancer, chronic diseases, bacterial and viral infections.

Assessment

Assessment task 1: Seminar and workshop assessments (weekly assessments) 22%

Assessment task 2: Mid-trimester test (45 minutes) 15%

Assessment task 3: Written report (1500 words) 23%

Assessment task 4: Examination (2 hours) 40%

Prescribed texts

Raymond G. Hill & Humphrey P. Rang. Drug Discovery and development second edition 2013.

Unit Fee Information

Unit fee information available soon

Return to previous page